seborrheic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed as mild-moderate SSD; 2. Outpatients between 18 and 75 years of age; 3. No topical or systemic therapy for seborrheic dermatitis has been administered within 4 weeks before baseline; 4. Able to complete study-related self-assessments and written records; 5. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients allergic to complex acid, salicylic acid shampoo, scalp moisturizing serum, or ketoconazole; 2. Use of preparations containing salicylic acid, ketoconazole, or other ingredients of the study products within 4 weeks prior to enrollment; 3. Women who were planning pregnancy, pregnant, or lactating; 4. Patients with severe cardiac, cerebral, hepatic, or renal diseases, psychiatric disorders, or overt immunosuppression; 5. Participation in other interventional clinical trials within the past 3 months; 6. Any other conditions judged by the investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The state of your gut microbes; | — |
Countries
China
Contacts
The 2nd Affiliated Hospital of Chongqing Medical University